KATHLEEN HARRIS: Open Payments
NPI 1144825191 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,482 in 38 payments from 7 companies in 2025. Trend: 2023 $7,471 · 2024 $10,443 · 2025 $6,482
Speaker / faculty: $4,704Food & beverage: $1,470Consulting: $224Travel & lodging: $84
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 15 | $5,509 |
| Novartis Pharmaceuticals Corporation | 12 | $494 |
| TG Therapeutics, Inc. | 5 | $168 |
| Genentech, Inc. | 1 | $120 |
| EMD Serono, Inc. | 2 | $88 |
| GENZYME CORPORATION | 2 | $80 |
| Celgene Corporation | 1 | $23 |
Products named: VUMERITY, KESIMPTA, TYSABRI, BRIUMVI, Ocrevus Zunovo, ZEPOSIA.
Industry payments across OH — which companies pay providers there.
